Published in PLoS One on October 07, 2013
Targeting potassium channels in cancer. J Cell Biol (2014) 1.15
The family of K2P channels: salient structural and functional properties. J Physiol (2015) 1.02
The role of protein-protein interactions in the intracellular traffic of the potassium channels TASK-1 and TASK-3. Pflugers Arch (2015) 0.81
Role of ion channels in regulating Ca²⁺ homeostasis during the interplay between immune and cancer cells. Cell Death Dis (2015) 0.81
Expression and localisation of two-pore domain (K2P) background leak potassium ion channels in the mouse retina. Sci Rep (2017) 0.75
In silico analysis identifies genes common between five primary gastrointestinal cancer sites with potential clinical applications. Ann Gastroenterol (2014) 0.75
A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib. PLoS One (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The hallmarks of cancer. Cell (2000) 113.05
ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (2004) 17.08
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia (2007) 10.74
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (2011) 5.40
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature (1984) 4.70
Functional significance of cell volume regulatory mechanisms. Physiol Rev (1998) 4.59
Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci (2001) 3.65
Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol Rev (2010) 3.39
Oncogenic potential of EAG K(+) channels. EMBO J (1999) 2.74
Ion channels and cancer. J Membr Biol (2005) 2.56
Potassium channels, proliferation and G1 progression. J Membr Biol (1996) 2.16
International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev (2005) 2.03
Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) (2004) 1.89
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol (1995) 1.88
Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell (2003) 1.76
Ion channels in cell proliferation and apoptotic cell death. J Membr Biol (2005) 1.69
A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene (2007) 1.69
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev (2012) 1.64
Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch Biochem Biophys (2007) 1.56
K+-dependent cerebellar granule neuron apoptosis. Role of task leak K+ channels. J Biol Chem (2003) 1.56
Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch (2004) 1.53
Role of ion channels and transporters in cell migration. Physiol Rev (2012) 1.52
herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res (2004) 1.49
Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer. EMBO Rep (2008) 1.46
Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol (2011) 1.37
Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev (2006) 1.34
Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer (2009) 1.26
Clinical relevance of ion channels for diagnosis and therapy of cancer. J Membr Biol (2005) 1.26
Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene (2009) 1.24
Potassium channels: new targets in cancer therapy. Cancer Detect Prev (2006) 1.18
The TASK background K2P channels: chemo- and nutrient sensors. Trends Neurosci (2007) 1.17
Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function. Proc Natl Acad Sci U S A (2003) 1.17
Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res (2007) 1.15
The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Mol Cancer (2010) 1.13
TREK-1 is a novel molecular target in prostate cancer. Cancer Res (2008) 1.12
Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis. Cancer Res (2001) 1.10
Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol Cancer Ther (2006) 1.04
Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines. World J Gastroenterol (2007) 1.03
Pancreatic two P domain K+ channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species. J Physiol (2004) 1.02
Expression and significance of HERG protein in gastric cancer. Cancer Biol Ther (2007) 1.02
Ionizing radiation induces migration of glioblastoma cells by activating BK K(+) channels. Radiother Oncol (2011) 1.00
Membrane potential depolarization decreases the stiffness of vascular endothelial cells. J Cell Sci (2011) 0.99
Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer (2005) 0.99
Potential identification of the O2-sensitive K+ current in a human neuroepithelial body-derived cell line. Am J Physiol (1999) 0.98
The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol (Oxf) (2009) 0.98
The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells. Mol Pharmacol (2006) 0.97
Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis. Int J Cancer (2008) 0.97
From the background to the spotlight: TASK channels in pathological conditions. Brain Pathol (2010) 0.97
Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration. Cell Signal (2009) 0.96
Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic cancer cells. J Biol Chem (2008) 0.96
Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep (2009) 0.95
Differential expression of potassium ion channels in human renal cell carcinoma. Int Urol Nephrol (2008) 0.94
Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels. Cell Res (2010) 0.94
Serum-activated K and Cl currents underlay U87-MG glioblastoma cell migration. J Cell Physiol (2011) 0.93
The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer Cell Int (2011) 0.92
Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells. Pflugers Arch (2011) 0.92
Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications. J Mol Med (Berl) (2012) 0.91
Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas (2009) 0.91
The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells. Biochem Biophys Res Commun (2008) 0.91
KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility. Exp Cell Res (2009) 0.90
Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J Cell Physiol (2012) 0.90
Altered expression of KCNK9 in colorectal cancers. APMIS (2004) 0.90
Expression and prognostic roles of Eag1 in resected esophageal squamous cell carcinomas. Dig Dis Sci (2007) 0.90
The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells. Mol Endocrinol (2011) 0.89
Potassium channels: novel emerging biomarkers and targets for therapy in cancer. Recent Pat Anticancer Drug Discov (2013) 0.88
Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231. BMC Pharmacol Toxicol (2013) 0.87
ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis (2009) 0.87
Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells. J Membr Biol (2010) 0.87
PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels. Oncol Rep (2011) 0.87
O2 sensing by recombinant TWIK-related halothane-inhibitable K+ channel-1 background K+ channels heterologously expressed in human embryonic kidney cells. Neuroscience (2005) 0.86
Knockdown of inwardly rectifying potassium channel Kir2.2 suppresses tumorigenesis by inducing reactive oxygen species-mediated cellular senescence. Mol Cancer Ther (2010) 0.85
Eag1 channels as potential cancer biomarkers. Sensors (Basel) (2012) 0.85
Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis. Clin Biochem (2011) 0.85
Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors. Biochim Biophys Acta (2011) 0.85
Depolarization potentiates TRAIL-induced apoptosis in human melanoma cells: role for ATP-sensitive K+ channels and endoplasmic reticulum stress. Int J Oncol (2012) 0.84
Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel. Acta Physiol (Oxf) (2011) 0.84
N-glycosylation-dependent control of functional expression of background potassium channels K2P3.1 and K2P9.1. J Biol Chem (2012) 0.84
Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway. BMC Cancer (2010) 0.83
Silencing of Kv4.1 potassium channels inhibits cell proliferation of tumorigenic human mammary epithelial cells. Biochem Biophys Res Commun (2009) 0.83
Involvement of Kv4.1 K(+) channels in gastric cancer cell proliferation. Biol Pharm Bull (2010) 0.83
Overexpression of hERG1 in resected esophageal squamous cell carcinomas: a marker for poor prognosis. J Surg Oncol (2008) 0.83
Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway. Cell Signal (2011) 0.83
Upregulation of ATP-sensitive potassium channels for estrogen-mediated cell proliferation in human uterine leiomyoma cells. Gynecol Endocrinol (2008) 0.83
Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma. Br J Neurosurg (2011) 0.82
DNA methylation of K(v)1.3 potassium channel gene promoter is associated with poorly differentiated breast adenocarcinoma. Cell Physiol Biochem (2009) 0.82
Reduced Kv1.3 potassium channel expression in human prostate cancer. J Membr Biol (2007) 0.82
Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas. J Pathol (2010) 0.81
Inhibition of TASK-3 (KCNK9) channel biosynthesis changes cell morphology and decreases both DNA content and mitochondrial function of melanoma cells maintained in cell culture. Melanoma Res (2011) 0.81
Activation of BK(Ca) channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells. PLoS One (2012) 0.80
Overexpression of potassium channel ether à go-go in human osteosarcoma. Neoplasma (2012) 0.80
Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells. Biochem Biophys Res Commun (2010) 0.80
Melanoma cells exhibit strong intracellular TASK-3-specific immunopositivity in both tissue sections and cell culture. Cell Mol Life Sci (2006) 0.79
Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade. Biochem Biophys Res Commun (2008) 0.79
Curcumin blocks Kv11.1 (erg) potassium current and slows proliferation in the infant acute monocytic leukemia cell line THP-1. Cell Physiol Biochem (2011) 0.77
Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med (Berl) (2003) 3.65
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis. Arthritis Rheum (2012) 3.38
Progranulin is a mediator of the wound response. Nat Med (2003) 3.27
Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest (2008) 2.77
Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron (2006) 2.53
International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol Rev (2003) 2.05
Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities. Protein Sci (2008) 1.60
Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev Dyn (2003) 1.58
The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin. Exp Cell Res (2005) 1.53
Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival. Cancer Res (2002) 1.52
Progranulin is expressed within motor neurons and promotes neuronal cell survival. BMC Neurosci (2009) 1.46
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. Cancer Res (2002) 1.42
Functional responses modified by predator density. Oecologia (2008) 1.22
Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β. Protein Cell (2010) 1.19
Rehabilitation of executive dysfunction following brain injury: "content-free" cueing improves everyday prospective memory performance. Neuropsychologia (2006) 1.19
International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems. Hum Pathol (2012) 1.16
Structure, function, and mechanism of progranulin; the brain and beyond. J Mol Neurosci (2011) 1.12
Progranulin is a stress-response factor in fibroblasts subjected to hypoxia and acidosis. Growth Factors (2007) 0.96
Regulation of progranulin expression in myeloid cells. Am J Physiol Regul Integr Comp Physiol (2006) 0.94
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines. Nat Med (2003) 0.93
Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading. Apoptosis (2006) 0.91
Airway chemotransduction: from oxygen sensor to cellular effector. Am J Respir Crit Care Med (2002) 0.89
Expression of TBX2 promotes anchorage-independent growth and survival in the p53-negative SW13 adrenocortical carcinoma. Cancer Lett (2009) 0.88
Walking and talking therapy: improving cognitive-motor dual-tasking in neurological illness. J Int Neuropsychol Soc (2009) 0.88
Development and application of mass spectrometric methods for the analysis of progranulin N-glycosylation. J Proteomics (2010) 0.87
Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy. Clin Cancer Res (2006) 0.87
Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trial. Trials (2013) 0.86
Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. Mol Neurodegener (2010) 0.85
Dendritic cells trigger tumor cell death by a nitric oxide-dependent mechanism. J Immunol (2007) 0.85
Expression of the growth factor progranulin in endothelial cells influences growth and development of blood vessels: a novel mouse model. PLoS One (2013) 0.84
N-glycosylation-dependent control of functional expression of background potassium channels K2P3.1 and K2P9.1. J Biol Chem (2012) 0.84
The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Exp Cell Res (2007) 0.83
Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine. Immunology (2003) 0.82
Dimensions of the Dysexecutive Questionnaire (DEX) examined using Rasch analysis. Neuropsychol Rehabil (2011) 0.82
Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models. Hum Mol Genet (2012) 0.81
Dendritic cells for the immunotherapy of cancer. Clin Oncol (R Coll Radiol) (2002) 0.80
Ecological validity of the Multiple Errands Test using predictive models of dysexecutive problems in everyday life. J Clin Exp Neuropsychol (2013) 0.79
Spatiotemporal expression pattern of progranulin in embryo implantation and placenta formation suggests a role in cell proliferation, remodeling, and angiogenesis. Reproduction (2008) 0.78
Computerised cognitive behavioural therapy (cCBT): a possible treatment for mood disorders experienced by people with neurological conditions? Neuropsychol Rehabil (2011) 0.78
Acid sensitive background potassium channels K2P3.1 and K2P9.1 undergo rapid dynamin-dependent endocytosis. Channels (Austin) (2013) 0.77
Impaired orientation discrimination and localisation following parietal damage: On the interplay between dorsal and ventral processes in visual perception. Cogn Neuropsychol (2004) 0.76
NICE on rehabilitation. New guidelines on rehabilitation likely to restrict practices and stifle innovation. BMJ (2013) 0.76
Exploration of use of SenseCam to support autobiographical memory retrieval within a cognitive-behavioural therapeutic intervention following acquired brain injury. Memory (2011) 0.75
Spanish, French, and British cross-cultural validation of the European Brain Injury Questionnaire. J Head Trauma Rehabil (2011) 0.75
The effect of a perceptual cognitive task on exercise performance: the dual-task condition after brain injury. Clin Rehabil (2003) 0.75
Validating independent ratings of executive functioning following acquired brain injury using Rasch analysis. Neuropsychol Rehabil (2012) 0.75